N-Glycans Are Involved in the Response of Caenorhabditis elegans to Bacterial Pathogens

Methods in Enzymology

Volumn 417, Issue , 2006, Pages 359-389

  Shi, Hui ^a   Tan, Jenny ^a   Schachter, Harry ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE; MANNOSE; N ACETYLGLUCOSAMINYLTRANSFERASE; N ACETYLLACTOSAMINE SYNTHASE;

CAENORHABDITIS ELEGANS; CARBOHYDRATE METABOLISM; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC CODE; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; STRAIN IDENTIFICATION; STRUCTURAL HOMOLOGY; WILD TYPE;

ANIMALS; CAENORHABDITIS ELEGANS; CARBOHYDRATE SEQUENCE; ESCHERICHIA COLI; IMMUNITY, NATURAL; MOLECULAR SEQUENCE DATA; NITROGEN; POLYSACCHARIDES; PSEUDOMONAS AERUGINOSA;

BACTERIA (MICROORGANISMS); CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; EUKARYOTA; HEXAPODA; VERTEBRATA;

EID: 33751228455     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)17022-6     Document Type: Review

References (116)

1. Aballay A., and Ausubel F.M. Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc. Natl. Acad. Sci. USA 98 (2001) 2735-2739
2. Aballay A., and Ausubel F.M. Caenorhabditis elegans as a host for the study of host-pathogen interactions. Curr. Opin. Microbiol. 5 (2002) 97-101
3. Aebi M., and Hennet T. Congenital disorders of glycosylation: Genetic model systems lead the way. Trends Cell Biol. 11 (2001) 136-141
4. Alegado R.A., Campbell M.C., Chen W.C., Slutz S.S., and Tan M.W. Characterization of mediators of microbial virulence and innate immunity using the Caenorhabditis elegans host-pathogen model. Cell Microbiol. 5 (2003) 435-444
5. Altmann F., Fabini G., Ahorn H., and Wilson I.B. Genetic model organisms in the study of N-glycans. Biochimie. 83 (2001) 703-712
6. Altmann F., Schwihla H., Staudacher E., Glossl J., and Marz L. Insect cells contain an unusual, membrane-bound beta-N-acetylglucosaminidase probably involved in the processing of protein N-glycans. J. Biol. Chem. 270 (1995) 17344-17349
7. Atienza-Samols S.B., Pine P.R., and Sherman M.I. Effects of tunicamycin upon glycoprotein synthesis and development of early mouse embryos. Dev. Biol. 79 (1980) 19-32
8. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K. "Current Protocols in Molecular Biology." (1993), John Wiley and Sons, New York, NY
9. Brenner S. The genetics of Caenorhabditis elegans. Genetics 77 (1974) 71-94
10. Bulik D.A., and Robbins P.W. The Caenorhabditis elegans sqv genes and functions of proteoglycans in development. Biochim. Biophys. Acta. 1573 (2002) 247-257
11. Burda P., and Aebi M. The dolichol pathway of N-linked glycosylation. BBA Gen. Subjects 1426 (1999) 239-257
12. Chang J.Y., and Korolev V.V. Specific toxicity of tunicamycin in induction of programmed cell death of sympathetic neurons. Exp. Neurol. 137 (1996) 201-211
13. Charuk J.H.M., Tan J., Bernardini M., Haddad S., Reithmeier R.A.F., Jaeken J., and Schachter H. Carbohydrate-deficient glycoprotein syndrome type II-An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS). Eur. J. Biochem. 230 (1995) 797-805
14. Chen S., Spence A.M., and Schachter H. Isolation of null alleles of the Caenorhabditis elegans gly-12, gly-13 and gly-14 genes, all of which encode UDP-GlcNAc: Alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I activity. Biochimie. 85 (2003) 391-401
15. Chen S.H., Zhou S.H., Sarkar M., Spence A.M., and Schachter H. Expression of three Caenorhabditis elegans N-acetylglucosaminyltransferase I genes during development. J. Biol. Chem. 274 (1999) 288-297
16. Chen W., and Stanley P. Five Lec1 CHO cell mutants have distinct Mgat1 gene mutations that encode truncated N-acetylglucosaminyltransferase I. Glycobiology 13 (2003) 43-50
17. Chitwood D.J., Lusby W.R., Thompson M.J., Kochansky J.P., and Howarth O.W. The glycosylceramides of the nematode Caenorhabditis elegans contain an unusual, branched-chain sphingoid base. Lipids 30 (1995) 567-573
18. Cipollo J.F., Awad A.M., Costello C.E., and Hirschberg C.B. N-Glycans of Caenorhabditis elegans are specific to developmental stages. J. Biol. Chem. 280 (2005) 26063-26072
19. Cipollo J.F., Costello C.E., and Hirschberg C.B. The fine structure of Caenorhabditis elegans N-glycans. J. Biol. Chem. 277 (2002) 49143-49157
20. Darby C., Cosma C.L., Thomas J.H., and Manoil C. Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 96 (1999) 15202-15207
21. Dennis J.W., Granovsky M., and Warren C.E. Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1473 (1999) 21-34
22. Epstein H.F., and Shakes D.C. Caenorhabditis elegans: Modern biological analysis of an organism. In: Wilson L., and Matsudaira P. (Eds). "Methods in Cell Biology" Vol. 48 (1995), Academic Press, San Diego
23. Fan X., She Y.M., Bagshaw R.D., Callahan J.W., Schachter H., and Mahuran D.J. A method for proteomic identification of membrane-bound proteins containing Asn-linked oligosaccharides. Anal. Biochem. 332 (2004) 178-186
24. Fan X., She Y.M., Bagshaw R.D., Callahan J.W., Schachter H., and Mahuran D.J. Identification of the hydrophobic glycoproteins of Caenorhabditis elegans. Glycobiology 15 (2005) 952-964
25. Finnie J.W. Effect of tunicamycin on hepatocytes in vitro. J. Comp. Pathol. 125 (2001) 318-321
26. Francis B.R., Paquin L., Weinkauf C., and Jarvis D.L. Biosynthesis and processing of Spodoptera frugiperda alpha-mannosidase III. Glycobiology 12 (2002) 369-377
27. Fukuda M. Roles of mucin-type O-glycans in cell adhesion. Biochim. Biophys. Acta 1573 (2002) 394-405
28. Gan Y.H., Chua K.L., Chua H.H., Liu B., Hii C.S., Chong H.L., and Tan P. Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system. Mol. Microbiol. 44 (2002) 1185-1197
29. Garsin D.A., Sifri C.D., Mylonakis E., Qin X., Singh K.V., Murray B.E., Calderwood S.B., and Ausubel F.M. A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. USA 98 (2001) 10892-10897
30. Gerdt S., Dennis R.D., Borgonie G., Schnabel R., and Geyer R. Isolation, characterization and immunolocalization of phosphorylcholine-substituted glycolipids in developmental stages of Caenorhabditis elegans. Eur. J. Biochem. 266 (1999) 952-963
31. Gerdt S., Lochnit G., Dennis R.D., and Geyer R. Isolation and structural analysis of three neutral glycosphingolipids from a mixed population of Caenorhabditis elegans (Nematoda:Rhabditida). Glycobiology 7 (1997) 265-275
32. Granovsky M., Fata J., Pawling J., Muller W.J., Khokha R., and Dennis J.W. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6 (2000) 306-312
33. Gravato-Nobre M.J., and Hodgkin J. Caenorhabditis elegans as a model for innate immunity to pathogens. Cell Microbiol. 7 (2005) 741-751
34. Gravato-Nobre M.J., Nicholas H.R., Nijland R., O'Rourke D., Whittington D.E., Yook K.J., and Hodgkin J. Multiple genes affect sensitivity of Caenorhabditis elegans to the bacterial pathogen Microbacterium nematophilum. Genetics 171 (2005) 1033-1045
35. Griffitts J.S., Haslam S.M., Yang T., Garczynski S.F., Mulloy B., Morris H., Cremer P.S., Dell A., Adang M.J., and Aroian R.V. Glycolipids as receptors for Bacillus thuringiensis crystal toxin. Science 307 (2005) 922-925
36. Griffitts J.S., Huffman D.L., Whitacre J.L., Barrows B.D., Marroquin L.D., Muller R., Brown J.R., Hennet T., Esko J.D., and Aroian R.V. Resistance to a bacterial toxin is mediated by removal of a conserved glycosylation pathway required for toxin-host interactions. J. Biol. Chem. 278 (2003) 45594-45602
37. Grunewald S., Matthijs G., and Jaeken J. Congenital disorders of glycosylation: A review. Pediatr. Res. 52 (2002) 618-624
38. Guerardel Y., Balanzino L., Maes E., Leroy Y., Coddeville B., Oriol R., and Strecker G. The nematode Caenorhabditis elegans synthesizes unusual O-linked glycans: Identification of glucose-substituted mucin-type O-glycans and short chondroitin-like oligosaccharides. Biochem. J. 357 (2001) 167-182
39. Haltiwanger R.S., and Lowe J.B. Role of glycosylation in development. Annu. Rev. Biochem. 73 (2004) 491-537
40. Hanneman A., Lapadula A., Ashline D., Zhang H., Schachter H., and Reinhold V. Aberrant protein N-glycosylation in Caenorhabditis elegans GnT-I triple knockout worms. Glycobiology 15 (2005) 1218
41. Hanneman A., and Reinhold V. Abundant and unusual N-linked glycans from the eukaryote, C. elegans. Glycobiology 13 (2003) 899-900
42. Haslam S.M., and Dell A. Hallmarks of Caenorhabditis elegans N-glycosylation: Complexity and controversy. Biochimie. 85 (2003) 25-32
43. Haslam S.M., Gems D., Morris H.R., and Dell A. The glycomes of Caenorhabditis elegans and other model organisms. Biochem. Soc. Symp. 69 (2002) 117-134
44. Hemming F.W. Biosynthesis. The Coenzymic Role of Phosphodolichols. In: Montreuil J., Vliegenthart J.F.G., and Schachter H. (Eds). "Glycoproteins" Vol. 29a (1995), Elsevier, Amsterdam, The Netherlands 127-143
45. Herscovics A. Importance of glycosidases in mammalian glycoprotein biosynthesis. Biochim. Biophys. Acta 1473 (1999) 96-107
46. Hirabayashi J., Hayama K., Kaji H., Isobe T., and Kasai K. Affinity capturing and gene assignment of soluble glycoproteins produced by the nematode Caenorhabditis elegans. J. Biochem. (Tokyo) 132 (2002) 103-114
47. Hodgkin J., Kuwabara P.E., and Corneliussen B. A novel bacterial pathogen, Microbacterium nematophilum, induces morphological change in the nematode C. elegans. Curr. Biol. 10 (2000) 1615-1618
48. Hoeflich J., Berninsone P., Goebel C., Gravato-Nobre M.J., Libby B.J., Darby C., Politz S.M., Hodgkin J., Hirschberg C.B., and Baumeister R. Loss of srf-3 encoded nucleotide sugar transporter activity in Caenorhabditis elegans alters surface antigenicity and prevents bacterial adherence. J. Biol. Chem. 279 (2004) 30440-30448
49. Houston K.M., and Harnett W. Structure and synthesis of nematode phosphorylcholine-containing glycoconjugates. Parasitology 129 (2004) 655-661
50. Hübel A., and Schwarz R.T. Dolichol Phosphate GlcNAc-1-P Transferase. In: Taniguchi N., Honke K., and Fukuda M. (Eds). "Handbook of Glycosyltransferases and Related Genes" (2002), Springer-Verlag, Tokyo, Japan 550-556
51. Ioffe E., and Stanley P. Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc. Natl. Acad. Sci. USA 91 (1994) 728-732
52. Jaeken J., and Carchon H. Congenital disorders of glycosylation: A booming chapter of pediatrics. Curr. Opin. Pediatr. 16 (2004) 434-439
53. Jaeken J., Schachter H., Carchon H., De Cock P., Coddeville B., and Spik G. Carbohydrate deficient Glycoprotein syndrome type II: A deficiency in Golgi localised N-acetylglucosaminyltransferase II. Arch. Dis. Child. 71 (1994) 123-127
54. Kaji H., and Isobe T. Protein database of Caenorhabditis elegans. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 787 (2003) 91-99
55. Kaji H., Saito H., Yamauchi Y., Shinkawa T., Taoka M., Hirabayashi J., Kasai K., Takahashi N., and Isobe T. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat. Biotechnol. 21 (2003) 667-672
56. Kawar Z., Karaveg K., Moremen K.W., and Jarvis D.L. Insect cells encode a class II {alpha}-mannosidase with unique properties. J. Biol. Chem. 276 (2001) 16335-16340
57. Kurz C.L., and Ewbank J.J. Caenorhabditis elegans: An emerging genetic model for the study of innate immunity. Nat. Rev. Genet. 4 (2003) 380-390
58. Kurz C.L., and Tan M.W. Regulation of aging and innate immunity in C. elegans. Aging Cell 3 (2004) 185-193
59. Laine R.A. A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 x 10(12) structures for a reducing hexasaccharide: The isomer barrier to development of single-method saccharide sequencing or synthesis systems. Glycobiology 4 (1994) 759-767
60. Lewis J.A., and Fleming J.T. Basic culture methods. Methods Cell Biol. 48 (1995) 3-29
61. Lin T.Y., Wang S.M., Fu W.M., Chen Y.H., and Yin H.S. Toxicity of tunicamycin to cultured brain neurons: Ultrastructure of the degenerating neurons. J. Cell Biochem. 74 (1999) 638-647
62. Link C.D., Silverman M.A., Breen M., Watt K.E., and Dames S.A. Characterization of Caenorhabditis elegans lectin-binding mutants. Genetics 131 (1992) 867-881
63. Lochnit G., Dennis R.D., and Geyer R. Phosphorylcholine substituents in nematodes: Structures, occurrence and biological implications. Biol. Chem. 381 (2000) 839-847
64. Lowe J.B. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr. Opin. Cell Biol. 15 (2003) 531-538
65. Lowe J.B., and Marth J.D. A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 72 (2003) 643-691
66. Mahajan-Miklos S., Rahme L.G., and Ausubel F.M. Elucidating the molecular mechanisms of bacterial virulence using non-mammalian hosts. Mol. Microbiol. 37 (2000) 981-988
67. Mahajan-Miklos S., Tan M.W., Rahme L.G., and Ausubel F.M. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96 (1999) 47-56
68. Marek K.W., Vijay I.K., and Marth J.D. A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality. Glycobiology 9 (1999) 1263-12671
69. Mawuenyega K.G., Kaji H., Yamuchi Y., Shinkawa T., Saito H., Taoka M., Takahashi N., and Isobe T. Large-scale identification of Caenorhabditis elegans proteins by multidimensional liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2 (2003) 23-35
70. Mello C., and Fire A. DNA transformation. Methods Cell Biol. 48 (1995) 451-482
71. Metzler M., Gertz A., Sarkar M., Schachter H., Schrader J.W., and Marth J.D. Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J. 13 (1994) 2056-2065
72. Millet A.C., and Ewbank J.J. Immunity in Caenorhabditis elegans. Curr. Opin. Immunol. 16 (2004) 4-9
73. Moremen K.W. Golgi alpha-mannosidase II deficiency in vertebrate systems: Implications for asparagine-linked oligosaccharide processing in mammals. Biochim. Biophys. Acta 1573 (2002) 225-235
74. Natsuka S., Adachi J., Kawaguchi M., Nakakita S.-I., Hase S., Ichikawa A., and Ikura K. Structure analysis of N-linked glycans in Caenorhabditis elegans. J. Biochem. (Tokyo) 131 (2002) 807-813
75. Paschinger K., Rendic D., Lochnit G., Jantsch V., and Wilson I.B. Molecular basis of anti-horseradish peroxidase staining in Caenorhabditis elegans. J. Biol. Chem. 279 (2004) 49588-49598
76. Paschinger K., Staudacher E., Stemmer U., Fabini G., and Wilson I.B. Fucosyltransferase substrate specificity and the order of fucosylation in invertebrates. Glycobiology 15 (2005) 463-474
77. Pittet M., Uldry D., Aebi M., and Conzelmann A. The N-glycosylation defect of cwh8{Delta} yeast cells causes a distinct defect in sphingolipid biosynthesis. Glycobiology 16 (2005) 155-164.
78. Politz S.M., Philipp M., Estevez M., O′Brien P.J., and Chin K.J. Genes that can be mutated to unmask hidden antigenic determinants in the cuticle of the nematode Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 87 (1990) 2901-2905
79. Pujol N., Link E.M., Liu L.X., Kurz C.L., Alloing G., Tan M.W., Ray K.P., Solari R., Johnson C.D., and Ewbank J.J. A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr. Biol. 11 (2001) 809-821
80. Riddle D.L., Blumenthal T., Meyer B.J., and Priess J.R. C. elegans II. "Cold Spring Harbor Monograph Series" Vol. 33 (1997), Cold Spring Harbor Laboratory Press, Plainview, NY
81. Ruiz-Diez B., Sanchez P., Baquero F., Martinez J.L., and Navas A. Differential interactions within the Caenorhabditis elegans-Pseudomonas aeruginosa pathogenesis model. J. Theor. Biol. 225 (2003) 469-476
82. Sambrook J., Fritsch E.F., and Maniatis T. "Molecular Cloning: A Laboratory Manual." (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
83. Sanger F., Nicklen S., and Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74 (1977) 5463-5467
84. Sarkar M., Leventis P.A., Silvescu C.I., Reinhold V.N., Schachter H., and Boulianne G.L. Null mutations in Drosophila N-acetylglucosaminyltransferase I produce defects in locomotion and a reduced lifespan. J. Biol. Chem. 281 (2006) 12776-12785
85. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem. Cell Biol. 64 (1986) 163-181
86. Schachter H. The "yellow brick road" to branched complex N-glycans. Glycobiology 1 (1991) 453-461
87. Schachter H. Biosynthesis. Glycosyltransferases Involved in the Synthesis of N-glycan Antennae. In: Montreuil J., Vliegenthart J.F.G., and Schachter H. (Eds). "Glycoproteins" Vol. 29a (1995), Elsevier, Amsterdam, The Netherlands 153-199
88. Schachter H. The joys of HexNAc. The synthesis and function of N- and O-glycan branches. Glycoconj. J. 17 (2000) 465-483
89. Schachter H. Protein glycosylation lessons from Caenorhabditis elegans. Curr. Opin. Struct. Biol. 14 (2004) 607-616
90. Schachter H. Deficient Glycoprotein Glycosylation in Humans and Mice. In: Fukuda M., Rutishauser U., and Schnaar R.L. (Eds). "Neuroglycobiology" (2005), Oxford University Press, Oxford 157-198
91. Schachter H., Chen S., Zhang W., Spence A.M., Zhu S., Callahan J.W., Mahuran D.J., Fan X., Bagshaw R.D., She Y.M., Rosa J.C., and Reinhold V.N. Functional post-translational proteomics approach to study the role of N-glycans in the development of Caenorhabditis elegans. Biochem. Soc. Symp. 69 (2002) 1-21
92. Schwientek T., Keck B., Levery S.B., Jensen M.A., Pedersen J.W., Wandall H.H., Stroud M., Cohen S.M., Amado M., and Clausen H. The Drosophila gene brainiac encodes a glycosyltransferase putatively involved in glycosphingolipid synthesis. J. Biol. Chem. 277 (2002) 32421-32429
93. Sifri C.D., Begun J., and Ausubel F.M. The worm has turned-microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13 (2005) 119-127
94. Spiro R.G. Protein glycosylation: Nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12 (2002) 43R-56R
95. Spiro R.G. Role of N-linked polymannose oligosaccharides in targeting glycoproteins for endoplasmic reticulum-associated degradation. Cell Mol. Life Sci. 61 (2004) 1025-1041
96. Stanley P. Functions of Carbohydrates Revealed by Transgenic Technology. In: Fukuda M., and Hindsgaul O. (Eds). "Molecular and Cellular Glycobiology" Vol. 30 (2000), Oxford University Press, Oxford 169-198
97. Surani M.A.H. Glycoprotein synthesis and inhibition of glycosylation by tunicamycin in pre-implantation mouse embryos: Compaction and trophoblast adhesion. Cell 18 (1979) 217-227
98. Tan J., Dunn J., Jaeken J., and Schachter H. Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am. J. Hum. Genet. 59 (1996) 810-817
99. Tan M.W. Identification of host and pathogen factors involved in virulence using Caenorhabditis elegans. Methods Enzymol. 358 (2002) 13-28
100. Tan M.W., and Ausubel F.M. Caenorhabditis elegans: A model genetic host to study Pseudomonas aeruginosa pathogenesis. Curr. Opin. Microbiol. 3 (2000) 29-34
101. Tan M.W., Mahajan-Miklos S., and Ausubel F.M. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. USA 96 (1999) 715-720
102. Tan M.W., Rahme L.G., Sternberg J.A., Tompkins R.G., and Ausubel F.M. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc. Natl. Acad. Sci. USA 96 (1999) 2408-2413
103. Toyoda H., Kinoshita-Toyoda A., and Selleck S.B. Structural analysis of glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate in vivo. J. Biol. Chem. 275 (2000) 2269-2275
104. Varki A. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3 (1993) 97-130
105. 2-protein: Transfer 'En Bloc' and Processing. In: Montreuil J., Vliegenthart J.F.G., and Schachter H. (Eds). "Glycoproteins" Vol. 29a (1995), Elsevier, Amsterdam, The Netherlands 145-152
106. Veronico P., Gray L.J., Jones J.T., Bazzicalupo P., Arbucci S., Cortese M.R., Di Vito M., and De Giorgi C. Nematode chitin synthases: Gene structure, expression and function in Caenorhabditis elegans and the plant parasitic nematode Meloidogyne artiellia. Mol. Genet. Genomics. 266 (2001) 28-34
107. Vitale A., and Chrispeels M.J. Transient N-acetylglucosamine in the biosynthesis of phytohemagglutinin: Attachment in the Golgi apparatus and removal in protein bodies. J. Cell Biol. 99 (1984) 133-140
108. Wandall H.H., Pedersen J.W., Park C., Levery S.B., Pizette S., Cohen S.M., Schwientek T., and Clausen H. Drosophila egghead encodes a beta 1,4-mannosyltransferase predicted to form the immediate precursor glycosphingolipid substrate for brainiac. J. Biol. Chem. 278 (2003) 1411-1414
109. Wang Y., Schachter H., and Marth J.D. Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II: A model for congenital disorder of glycosylation type IIa. Biochim. Biophys. Acta 1573 (2002) 301-311
110. Wang Y., Tan J., Sutton-Smith M., Ditto D., Panico M., Campbell R.M., Varki N.M., Long J.M., Jaeken J., Levinson S.R., Wynshaw-Boris A., Morris H.R., Le D., Dell A., Schachter H., and Marth J.D. Modeling human congenital disorder of glycosylation type IIa in the mouse: Conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 11 (2001) 1051-1070
111. Wood W.B. The Nematode. "Caenorhabditis elegans" (1988), Cold Spring Harbor Laboratory Press, Plainview, NY
112. Yamada S., Van Die I., Van den Eijnden D.H., Yokota A., Kitagawa H., and Sugahara K. Demonstration of glycosaminoglycans in Caenorhabditis elegans. FEBS Lett. 459 (1999) 327-331
113. Ye Z., and Marth J.D. N-glycan branching requirement in neuronal and post-natal viability. Glycobiology 14 (2004) 547-558
114. Zhang W., Cao P., Chen S., Spence A.M., Zhu S., Staudacher E., and Schachter H. Synthesis of paucimannose N-glycans by Caenorhabditis elegans requires prior actions of UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I, alpha-3,6-mannosidase II and a specific membrane-bound beta-N-acetylglucosaminidase. Biochem. J. 372 (2003) 53-64
115. Zhou D. Why are glycoproteins modified by poly-N-acetyllactosamine glyco-conjugates?. Curr. Protein Pept. Sci. 4 (2003) 1-9
116. Zhu S., Hanneman A., Reinhold V.N., Spence A.M., and Schachter H. Caenorhabditis elegans triple null mutant lacking UDP-N-acetyl-D-glucosamine:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I. Biochem. J. 382 (2004) 995-1001